Understanding Abbott’s Alere Acquisition: What We Can Expect Fri, 24 Nov 2017 15:31:24 +0000 On October 3, 2017, Abbott announced the completion of its acquisition of Alere, which has had troubles since the initial announcement in February 2016.
Inside Abbott’s Neuromodulation Business Growth Fri, 24 Nov 2017 14:01:31 +0000 Abbott's Medical Devices segment has products for rhythm management, heart failure, electrophysiology, structural heart diseases, neuromodulation, and more.
Should You Sell Abbott Laboratories (ABT) At This PE Ratio? Thu, 23 Nov 2017 16:01:04 +0000 Abbott Laboratories (NYSE:ABT) trades with a trailing P/E of 47.4x, which is higher than the industry average of 41.8x. Although some investors may jump to the conclusion that you shouldRead More...
Inside Abbott’s Growth: Understanding the Major Drivers Thu, 23 Nov 2017 12:34:23 +0000 Abbott Laboratories (ABT) registered sales of ~$6.8 billion for 3Q17, which represents YoY (year-over-year) sales growth of ~28.8% on a reported basis.
Abbott on the Street: Analyst Recommendations Wed, 22 Nov 2017 21:51:56 +0000 Abbott registered strong 3Q17 results, surpassing estimates for both sales and earnings and reporting healthy growth across all of its business segments.
ETFs with exposure to Abbott Laboratories : November 20, 2017 Mon, 20 Nov 2017 16:22:26 +0000 Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Abbott Laboratories Here are 5 ETFs with the largest exposure to ABT-US. Comparing the performance and risk of Abbott Laboratories with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
(Read more...)
Trade of the Day: Abbott Laboratories (ABT) Mon, 20 Nov 2017 13:57:00 +0000 To receive further updates on this Abbott Laboratories (NYSE:ABT) trade as well as an alert when it’s time to take profits, sign up for a risk-free trial of SlingShot Trader today.
*Winners defined as our Top Picks that increased 20% or more within a 6-month period.
Red Letters imply that that particular criteria did not meet minimum requirements, e.g., a low GSA Rank would show it in red.
___ Red Line On Graph Shows a Trailing Stop Loss Based on Support and Resistance Levels. See how it works.
___ Blue Line On Graph Shows the 10-Week Moving Average.
___ Magenta Line On Graph Shows the 40-Week Moving Average.
Disclaimer The stock selections in our stock investing and stock trading database are not stock recommendations, but simply represent applications of a stock investing process. All materials, including our Top Stock Picks, are provided for information purposes only and should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security. Growth Stock Analytics, LLC is not responsible for gains/losses that may result in investing or trading in these securities. All information is believed to be obtained from reliable sources, but there is no guarantee that the information supplied is accurate, complete or timely. There is no guarantee or warranty with regard to the results obtained from its use. There is no guarantee of suitability or potential value of any particular investment or information source. You acknowledge that your requests for this information are unsolicited and shall neither constitute nor be considered investment advice. Past investing performance is not an indication of future performance results. Investing and trading in stocks is risky. Investors are encouraged to consult a registered stock broker or investment adviser before making any investing decisions. The interpretations and opinions expressed herein are solely those of Growth Stock Analytics, LLC, and not of any other individual or organization.